Cargando…
Predictors of Acute Hematologic Toxicity in Women Receiving Extended-Field Chemoradiation for Cervical Cancer: Do Known Pelvic Radiation Bone Marrow Constraints Apply?
PURPOSE: Patients with cervical cancer who are at high risk for para-aortic lymphatic involvement may receive extended-field chemoradiation (EF-CRT), with inclusion of the para-aortic region. Increased radiation to bone marrow (BM) may heighten hematologic toxicity (HT) and affect timely delivery of...
Autores principales: | Hara, Jared H.L., Jutzy, Jessica M.S., Arya, Ritu, Kothari, Rajul, McCall, Anne R., Howard, Andrew R., Hasan, Yasmin, Cursio, John F., Son, Christina H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677190/ https://www.ncbi.nlm.nih.gov/pubmed/36420189 http://dx.doi.org/10.1016/j.adro.2022.100998 |
Ejemplares similares
-
Opioid Use in Patients With Cervical Cancer at Two Urban Medical Centers
por: Arya, Ritu, et al.
Publicado: (2021) -
Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation
por: Kumar, T, et al.
Publicado: (2019) -
Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer
por: Robinson, Maxwell, et al.
Publicado: (2020) -
Impact of hematologic toxicities during concurrent chemoradiation for cervical cancer
por: Shi, Feiya, et al.
Publicado: (2022) -
The role of bone marrow and spleen irradiation in the development of acute hematologic toxicity during chemoradiation for esophageal cancer
por: Chin, Alexander L., et al.
Publicado: (2018)